XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating activities:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 9,275 $ 8,391
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]    
Depreciation and amortization 10,890 10,469
Deferred income taxes and related valuation allowance (1,825) 1,272
Net loss (gain) on sale of real estate, investments and other (467) 485
Stock-based compensation 1,981 751
Amortization of deferred financing costs 483 430
Unrealized Gain (Loss) on Derivatives 231 (192)
Gain (Loss) on Sale of Assets and Asset Impairment Charges 0 (173)
Other Operating Activities, Cash Flow Statement 2,389 2,139
Changes in operating assets and liabilities, net of effects of business acquisitions:    
Trade accounts receivable (7,649) 11,265
Inventories (19,214) (21,467)
Prepaid expenses and other (2,800) 359
Increase (Decrease) in Other Operating Assets (636) (143)
Trade accounts payable 1,718 (15,720)
Increase (Decrease) in Accrued Liabilities (8,668) (6,938)
Increase (Decrease) in Other Noncurrent Liabilities (2,955) (2,451)
Net cash provided by (used for) operating activities (17,247) (11,177)
INVESTING ACTIVITIES:    
Proceeds from Sale and Maturity of Marketable Securities 1,100 650
Payments to Acquire Marketable Securities (906) (1,226)
Payments to Acquire Property, Plant, and Equipment (5,273) (2,953)
Proceeds from Equity Method Investment, Distribution, Return of Capital 0 313
Payments to Acquire Businesses, Net of Cash Acquired (107,605) (1,616)
Net cash provided by (used for) investing activities (112,684) (4,832)
FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock 225 415
Repayment of debt (10,143) (10,128)
Proceeds from Issuance of Long-term Debt 120,000 0
Proceeds from Issuance or Sale of Equity (2,046) 0
Proceeds from Derivative Instrument, Financing Activities 6,053 6,163
Payments for Derivative Instrument, Financing Activities (6,298) (6,022)
Payments of Dividends (2,004) (1,996)
Other (1,802) (1,313)
Net cash provided by (used for) financing activities 103,985 (12,881)
Effect of exchange rate changes on cash (236) (840)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (26,182) (29,730)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents 107,244 85,910
Capital Expenditures Incurred but Not yet Paid 205 204
Supplementary cash flow data:    
Interest Paid, Excluding Capitalized Interest, Operating Activities 6,786 5,741
Income taxes paid, net of refunds 4,701 3,940
Restricted Cash $ 250 $ 250